TERMIUM Plus®

The Government of Canada’s terminology and linguistic data bank.

OXALIPLATIN [1 record]

Record 1 2014-09-25

English

Subject field(s)
  • Medication
Universal entry(ies)
CONT

Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. It is typically administered in combination with fluorouracil and leucovorin in a combination known as Folfox for the treatment of colorectal cancer. Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility.

OBS

Active ingredient sold under a large number of commercial (trade) names, among which: Exolatin.

French

Domaine(s)
  • Médicaments
Entrée(s) universelle(s)
CONT

L'oxaliplatine appartient au groupe de médicaments qui combattent le cancer et que l'on appelle antinéoplasiques; elle se classe plus précisément dans le groupe d'antinéoplasiques désignés composés de platine. L'oxaliplatine prévient la croissance des cellules cancéreuses en parasitant l'action du matériel génétique (ADN) qui est nécessaire à leur reproduction.

OBS

Principe actif commercialisé, entre autres, sous les noms de Exolatin et Exolatine.

Spanish

Save record 1

Copyright notice for the TERMIUM Plus® data bank

© Public Services and Procurement Canada, 2024
TERMIUM Plus®, the Government of Canada's terminology and linguistic data bank
A product of the Translation Bureau

Features

Language Portal of Canada

Access a collection of Canadian resources on all aspects of English and French, including quizzes.

Writing tools

The Language Portal’s writing tools have a new look! Easy to consult, they give you access to a wealth of information that will help you write better in English and French.

Glossaries and vocabularies

Access Translation Bureau glossaries and vocabularies.

Date Modified: